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Abstract
Background: As we enter an era when testing millions of SNPs in a single gene association study will become the
standard, consideration of multiple comparisons is an essential part of determining statistical significance.
Bonferroni adjustments can be made but are conservative due to the preponderance of linkage disequilibrium (LD)
between genetic markers, and permutation testing is not always a viable option. Three major classes of corrections
have been proposed to correct the dependent nature of genetic data in Bonferroni adjustments: permutation
testing and related alternatives, principal components analysis (PCA), and analysis of blocks of LD across the
genome. We consider seven implementations of these commonly used methods using data from 1514 European
American participants genotyped for 700,078 SNPs in a GWAS for AIDS.
Results: A Bonferroni correction using the number of LD blocks found by the three algorithms implemented by
Haploview resulted in an insufficiently conservative threshold, corresponding to a genome-wide significance level
of a = 0.15 - 0.20. We observed a moderate increase in power when using PRESTO, SLIDE, and simpleℳ when
compared with traditional Bonferroni methods for population data genotyped on the Affymetrix 6.0 platform in
European Americans (a = 0.05 thresholds between 1 × 10
-7 and 7 × 10
-8).
Conclusions: Correcting for the number of LD blocks resulted in an anti-conservative Bonferroni adjustment. SLIDE
and simpleℳ are particularly useful when using a statistical test not handled in optimized permutation testing
packages, and genome-wide corrected p-values using SLIDE, are much easier to interpret for consumers of GWAS
studies.
Background
Since the first successful genome-wide association
studies (GWAS) in 2005, over 600 GWAS have been
reported [1]. Due in large part to rapid advances in gen-
otyping technology and standardized guidelines for
reporting statistical evidence, the multitude of compari-
sons made in a GWAS will result in both false positive
(Type 1 errors) and, if the correction for multiple com-
parisons is overly conservative or power is inadequate,
false negative (Type 2 errors) results.
The probability of a Type I error (incorrectly ascribing
scientific significance to a statistical test) is generally
controlled by setting the significance level, a,f o rat e s t ,
but the probability of making at least one Type I error
in a study,
P Study-wide Type I error 1 1 () =− − () , 
n
is a function of n, the number of independent com-
parisons made, as well as a. The direct application to a
GWAS is that, with a significance level typical to small
studies and candidate gene studies (e.g. a =0 . 0 5 ,a =
0.01, a = 0.001), the probability of not committing a
GWAS-wide Type I error is very small.
The standard for evidence of significance in GWAS to
securely identify a genotypephenotype association in
European Americans is generally considered to be p < 5
×1 0
-8 or p < 1 × 10
-8,f o ra = 0.05 and 0.01, respec-
tively [2-5]. This standard is based on a Bonferroni cor-
rection for an assumed million independent variants in
the human genome. As a consequence, the avoidance of
Type 1 errors may inflate Type 2 errors. This is espe-
cially true for analyses with low power, such as rare
diseases where patient numbers are limited, low
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sizes. This conundrum can be resolved with extremely
large study sizes, but in practice this is not always cost
efficient or practical. These issues should be major con-
siderations both for designing GWAS and interpreting
GWAS results.
Several methods are commonly used to control the
GWAS-wide Type I error rate: p-value adjustments for
multiple comparisons have long been used when making
multiple comparisons [6]; the use of q-values, a measure
of the false discovery rate, has been proposed as a way
to indirectly measure and control the Type I error rate
[7]; a two-stage analysis of the data can be used not
only to decrease the Type I error rate [8], but also to
decrease the genotyping costs incurred [9]; genotype
i m p u t a t i o nc a nr e s u l ti nan e ti n c r e a s ei ns t a t i s t i c a l
power [10,11].
A Bonferroni adjustment fits our problem particularly
well because many comparisons are made and a GWAS
is considered agnostic, with no prior hypotheses [12].
Several studies have estimated the number of statistical
comparisons made in a GWAS [2-5], but the universal
application of a one-size-fits-all significance level to
GWAS studies is inappropriate. Power to detect associa-
tions is determined, in large part, by allele frequencies
and their effect sizes; since these variables are constants,
only sample size can be adjusted. As the sample size
increases, the power to detect low frequency and/or
small effect size genetic variants also increases. Newer
SNP arrays, designed to more fully capture the range of
SNPs in diverse human populations and to include rare
SNPs hypothesized to be more likely to have larger
effect sizes, will increase the number of independent
statistical comparisons [4]. Additionally, the dependent
nature of genetic data, where SNPs in linkage disequili-
brium (LD) are correlated to some degree, may lead to
over-correction when using Bonferroni adjustments.
One of the key assumptions of a Bonferroni adjustment
is that all comparisons are independent. Neighboring
SNPs on a chromosome tend to be inherited together in
blocks and are not independent [3], making a strict Bon-
ferroni adjustment overly conservative.
One relevant question is then not how many SNPs are
being tested, but how many independent statistical com-
parisons are being made. In the context of a principal
components analysis (PCA) of the genotype data, the
number of independent comparisons can be defined as
the number of principal components accounting for a
large portion (99.5% has been suggested) of the variance
in the data [13]. The set of informative SNPs repre-
sented by these components could be used to infer the
remainder of the data set with a high degree of fidelity,
and can be used to make a Bonferroni adjustment with
the desired GWAS-wide significance level:


GWAS
Informative
=
n
.
What is not clear, however is which SNPs fall into the
informative set, so all SNPs are tested. The assumption
is then made that the test statistics are distributed simi-
larly to the test statistics from an analysis including only
the informative SNPs. Based on the simulations done by
Gao et. al. this seems to be a reasonable assumption
[13].
Another relevant question is how to adjust the
p-values directly, rather than relying on a significance
threshold [14]. These corrected p-values, measuring sig-
nificance on the genome-wide scale, have the added
benefit of easier interpretation. For example, comparing
two uncorrected p-values, 6.8 × 10
-8 and 4.1 × 10
-10,
becomes much more tractable after a genome-wide cor-
rection, resulting in corrected p-values of 0.0291 and
0.0004, respectively.
There have been a number of studies attempting to
provide an accurate picture of how SNPs, and/or statis-
tical tests of SNPs, are correlated in genome-wide stu-
dies. These fall into three general categories: variations
and alternatives to permutation testing [14,15], principal
components analysis [13,16-18], and analysis of the
underlying LD structure in the genome [19-21].
We have recently genotyped 1514 European Ameri-
cans for 700,078 SNPs using the Affymetrix 6.0 platform
in a GWAS to search for AIDS restriction genes. Here
we compare traditional Bonferroni significance thresh-
olds with methods from each of these statistical correc-
tion strategies to identify an appropriate measure of
significance in our GWAS: 1) PRESTO, an optimized
permutation algorithm [15] verified by PERMORY [22];
2) the Sliding-window method for Locally Inter-corre-
lated markers with asymptotic Distribution Errors cor-
rected (SLIDE) program, an alternative to permutation
testing, developed to correct p-values in a GWAS using
a multivariate normal distribution-based correction
[14,23]; 3) the simpleℳ method, specifically developed
to calculate the number of informative SNPs being
tested in a GWAS using a principal components analysis
[13]; 4) the number of LD blocks found by the Gabriel,
Solid Spine of LD, and 4-Gamete algorithms, as imple-
mented in Haploview [24].
Our aim is to identify the most appropriate method for
obtaining accurate GWAS-wide significance thresholds
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the best method being one that results in an accurate
estimate of the number of comparisons and has reason-
able computational requirements.
Methods
GWAS Data
After filtering for a 90% sample call rate, 1,514 Eur-
opean Americans were successfully genotyped on the
Affymetrix 6.0 platform. These subjects consisted of
1,255 HIV- infected and 259 HIV-negative individuals
at risk of HIV infection; clinical categories were dis-
tributed randomly across plates and batch effects were
monitored. We chose 700,078 SNPs, after filtering
each SNP for >95% call rate, Hardy-Weinberg equili-
brium, Mendel errors, and a minor allele frequency
below 1%. After re-clustering and filtering bad SNPs,
all sample call rates were >95% with an average call
rate of 98.9%. Individuals were unrelated, with the
exception of 8 CEPH trios used to check for Mendel
errors in the genetic data. A principal components
analysis of the genetic data using Eigensoft was used to
identify population structure. No significant outliers
were identified, however, since there is some stratifica-
tion in European American populations, SNPs that
contributed significantly to population structure were
tagged in subsequent analyses [25]. Association statis-
tics were not used for the purposes of this paper,
except where indicated in the multiple comparisons
methods below.
To address the concern that an excess number of
cases to controls would lead to less generalizable results,
we analyzed a random sample of 259 cases with all 259
controls. Other than the changes in case/control ratio
and sample size, all other variables were left unchanged.
Variations and Alternatives to Permutation Testing
PRESTO: The software package, PRESTO, was used to
permute case/control status 10,000 times, and the mini-
mum Mantel trend test p-value for all SNPs in the gen-
ome, comparing cases with controls, was recorded for
each permuted data set [15]. These minimum p-values
were then used to estimate the uncorrected distribution
of p-values under the null hypothesis of no true associa-
tions in the study. Each p-value was then corrected by
finding the corresponding percentile of the distribution
of uncorrected p-values, and a significance threshold for
a study-wide significance level of a was be obtained by
finding the a
th percentile of the uncorrected distribu-
tion. This distribution was used as the standard by
which each method’s accuracy is gauged, and corre-
sponding significance levels for all other methods were
estimated using this distribution. Results from PRESTO
were compared with the results from PERMORY,
another optimized permutation testing software package
that was recently released [22].
SLIDE: The SLIDE software package was used to
implement a multivariate normal distribution-based
approximation to a permutation test, using the quantita-
tive trait option, with 10,000 iterations [14,23]. For com-
parisons with the other methods considered, SLIDE
corrected p-values were used to estimate the GWAS-
wide significance threshold by finding a corrected
p-value equal to the desired study-wide significance.
level, a.
Principal Components Analysis
Simpleℳ: The simpleℳ method [13], based on a princi-
pal components analysis of the data, was implemented
in R, version 2.9.0 [26], following the example code
provided by Gao et al. https://dsgweb.wustl.edu/rgao/
simpleM_Ex.zip. This measure of the number of infor-
mative SNPs was then used in a Bonferroni adjustment
to estimate the GWAS-wide significance threshold. Each
chromosome was broken into regions of approximately
5,000 SNPs due to computational constraints. To choose
appropriate regions, with as little LD between adjacent
regions as possible, we chose cut points between LD
blocks identified by Haploview. A second analysis using
the largest regions possible, given the memory available,
was also explored to see if results were dependent on
the region size.
Analysis of Underlying LD
LD blocks were inferred in our GWAS data using the
three methods available in Haploview [24]. The number
of LD blocks across the human genome, including inter-
block SNPs (i.e. singleton SNPs), was used in a Bonfer-
roni adjustment to estimate GWAS-wide significance
thresholds [27]. Entire chromosomes could not be ana-
l y z e d ,d u et om e m o r yc o n s t r a i n t s ,s os m a l l e rr e g i o n s
were analyzed. All SNPs from the last full LD block of
the previous region were included in the analysis of the
next region to ensure complete LD blocks.
The Gabriel protocol, the default method for Haplo-
view, was used with an upper D’ confidence interval
bound of 0.98, a lower D’ confidence interval bound of
0.70, and with 5% of informative markers required to be
in strong LD [28]. The Solid Spine of LD algorithm [29]
was used with minimum D’ value of 0.8, as suggested by
Duggal et al. [21]. The 4-Gamete test was run setting
the cutoff for frequency of the fourth pairwise haplotype
at 1% [30,31].
Results and Discussion
Variations and Alternatives to Permutation Testing
PRESTO: The permutation based significance threshold
from PRESTO was 7.6 × 10
-8 (see Table 1). By
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had a significance threshold of 1.4 × 10
-7 (see Table 2);
this corresponds to an a level of 0.09 when compared
to the analysis of the full data set. These results were
consistent with an analysis using PERMORY on the
same subset and probably reflect the decrease in statisti-
cal power associated with the smaller sample size. Per-
mutation tests are the gold standard for identifying
appropriate significance thresholds, and are computa-
tionally efficient when optimized solutions exist for a
particular statistical test. As we see in Table 2, these
results are very specific to each study. One drawback of
permutation testing is the computational burden that
arises when no optimized solutions exist (e.g. when
modeling survival or longitudinal data). In such a case,
permutation testing can be impractical and one of the
other methods considered here would be more
appropriate.
Bonferroni: The standard Bonferroni correction, simply
using the total number of SNPs tested in the genome-
wide significance level calculation, was 7.1 × 10
-8,w h i c h
corresponded to a genome-wide significance level of a ≈
0.05 when compared with PRESTO (see Table 1). While
a permutation test may not result in a large improve-
ment in the corresponding genome-wide significance
level when compared with a standard Bonferroni correc-
tion in this SNP set, other, denser SNP sets will result
in greater disparities in significance levels.
SLIDE: The significance threshold identified by SLIDE
was 1.1 × 10
-7, which corresponded to a genome-wide
significance level of a = 0.07 when compared with PRE-
STO (see Table 1). The significance threshold found in
the analysis of the smaller sample was remarkably simi-
lar, differing only by 5 × 10
-9 (see Table 2). Over all,
these results indicate that SLIDE is an excellent alterna-
tive to permutation testing. Additionally, the corrected
p-values provide increased ease in interpretation of
GWAS results.
Principal Components Analysis
simpleℳ: The significance threshold based on the num-
ber of effective SNPs identified by the simpleℳ algo-
rithm was 8.2 × 10
-7, corresponding to a genome-wide
significance level of a ≈ 0.05 when compared with the
PRESTO results. As with SLIDE, the analysis of the
smaller sample was remarkably similar, differing only by
8×1 0
-10. These results indicate that simpleℳ is also an
excellent alternative to a full permutation test. However,
because of the concern of how variations in region size
would affect the accuracy of the simpleℳ analysis,
r e g i o n sw i t ha sm a n yS N P sa sw eh a dc o m p u t a t i o n a l
resources to analyze (some regions included nearly
30,000 SNPs, others consisted of entire chromosomes)
were compared to the results in Table 1. The corre-
sponding thresholds differed by less than 6 × 10
-9.I ti s
important to note, however, that since this is an O(n
2)
problem, the memory and serial time required to ana-
lyze these larger regions increases rapidly with the size
of the regions analyzed. Regions containing more than a
few thousand SNPs, however, seem to result in very
similar significance thresholds in this data set, and the
computational resources required are reasonable for
regions of a few thousand SNPs (see Figure 1).
The simpleℳ method is currently the fastest way to
calculate the effective number of independent tests in a
GWAS [32], but due to the O(n
2) nature of this algorithm
the genome needs to be broken up into small regions to
maintain this computational speed. This adds complexity
to the analysis and requires a significant amount of pre-
analysis. Considering the many examples of long range
LD across the genome, simpleℳ could also lead to a
slightly more conservative estimate in some studies [14].
Analysis of Underlying LD
The three LD-based methods using Haploview are the
least conservative, with significance thresholds between
2.72 × 10
-7 and 3.71 × 10
-7, corresponding to a levels
between 0.15 and 0.20 as compared to permutation test-
ing using PRESTO (see Table 1). Thus, it appears that
the use of LD blocks to construct Bonferroni signifi-
cance thresholds is anti-conservative in this data set. We
also explored alternate parameters but did not observe a
Table 1 Summary of Analysis Results
Method Significance Threshold Corresponding a level
Bonferroni 0.71 × 10
-7 0.046
PRESTO 0.76 × 10
-7 0.05
simpleℳ 0.82 × 10
-7 0.053
SLIDE 1.09 × 10
-7 0.068
Gabriel 2.72 × 10
-7 0.151
4-Gamete 3.06 × 10
-7 0.166
Solid spine 3.71 × 10
-7 0.195
The significance threshold for each method is shown (aGWAS = 0.05), as well
as the corresponding genome-wide a level when compared with the PRESTO
method. A strict Bonferroni significance threshold is also given.
Table 2 Difference in Significance Threshold in a Subset
of the Data
Method Δ Significance Threshold
simpleℳ -8 × 10
-11
4-Gamete -8 × 10
-10
SLIDE -5 × 10
-9
Gabriel -6 × 10
-8
PRESTO 7 × 10
-7
Solid spine -8 × 10
-7
The difference in significance threshold is given, comparing an analysis of the
full data set to a subset of the data with an equal number of cases and
controls (1,514 and 518 individuals, respectively).
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level when severely restricting the definition of haplo-
types (see Table 3).
Nicodemus et al. [27] noted that estimates may be
more or less conservative under varying levels of LD.
An alternate LD algorithm or parameter constraints
could be found that would result in a more accurate
estimate [33], but this would vary significantly
depending on the sample size, the set of SNPs, and
the underlying level of LD structure in the population.
This is further illustrated in the large differences
found using the Gabriel and Solid Spine of LD
algorithms on a subset of the individuals in this study
(see Table 2). While LD blocks do provide key infor-
mation on patterns of LD and how SNPs are corre-
lated, providing invaluable information for interpreting
GWAS results and for the planning of follow-up stu-
dies, we find the use of significance thresholds derived
from LD blocks to be too variable for general applica-
tion to GWAS data.
Conclusions
A one-size-fits-all Bonferroni correction, although con-
servative, may not result in a large Type II error rate
w i t has a m p l es i z ei nt h et e n so ft h o u s a n d s ,b u ta st h e
sample size drops, so does statistical power. In studies
where gathering large numbers of cases is prohibitive
(e.g. when disease prevalence is low), a Bonferroni cor-
rection becomes overly conservative by detrimentally
inflating the Type II error rate. The methods considered
here can ameliorate this loss of power and make inter-
pretation of study results less enigmatic.
The results from the PRESTO, SLIDE and simpleℳ
methods appear to be equally good in population data
genotyped on the Affymetrix 6.0 platform in European
Americans (a = 0.05 thresholds between 1 × 10
-7 and 8
×1 0
-8), and each presents a modest gain in power over
the strict Bonferroni thresholds advocated by some
[2-5]. The SLIDE and simpleℳ methods may be less
dependent on the number of individuals in the study,
and will be particularly useful when using a statistical
test that is not supported by optimized permutation
packages (e.g. when modeling survival or longitudinal
data) and when the SNPs being tested are sufficiently
dense. SLIDE not only has much nicer computational
properties when compared to simpleℳ,b u tt h ec o r -
rected p-values measuring significance on the genome-
wide scale are easier to interpret. While the idea of an
even standard across studies is appealing, the traditional
standard of presenting p-values in the context of the
study more accurately represents the data.
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Table 3 Comparison of a levels when restricting the
definition of a haplotype
Method Parameters Significance
Threshold
Corresponding a
level
Gabriel D’U > 0.98 2.72 × 10
-7 0.151
D’L > 0.70
D’U > 0.98 2.11 × 10
-7 0.12
D’L > 0.85
4-Gamete Cutoff = 1% 3.06 × 10
-7 0.166
Cutoff =
0.5%
2.50 × 10
-7 0.139
Solid
spine
D’ = 0.80 3.71 × 10
-7 0.195
D’ = 0.95 2.79 × 10
-7 0.155
Significance thresholds with corresponding a levels are given for each
haplotype calling method with the standard parameters and a set of more
restricted parameters. D’U and D’L represent the, upper and lower confidence
limits of D’, respectively.
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Figure 1 Change in computation time and significance
threshold for varying region sizes. The change in serial
computation time (solid black line) and significance threshold (dotted
blue line) are plotted as a function of the mean number of SNPs in
each region in a GWAS-wide analysis using the simpleℳ method.
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